278 related articles for article (PubMed ID: 15944050)
1. Relevance of high-dose chemotherapy in solid tumours.
Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
[TBL] [Abstract][Full Text] [Related]
2. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
Pinkerton CR
Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
[TBL] [Abstract][Full Text] [Related]
3. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
Handberg J; Hansen SW
Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survival.
Gisselbrecht C
Eur J Cancer; 1994; 30A Suppl 3():S30-3. PubMed ID: 7535070
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy in adult sarcomas: no standard yet.
Seynaeve C; Verweij J
Semin Oncol; 1999 Feb; 26(1):119-33. PubMed ID: 10073568
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
[TBL] [Abstract][Full Text] [Related]
7. Curative cancer chemotherapy.
Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors.
de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH
Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy in ovarian carcinoma.
Herrin VE; Thigpen JT
Semin Oncol; 1999 Feb; 26(1):99-105. PubMed ID: 10073566
[TBL] [Abstract][Full Text] [Related]
10. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy for breast cancer.
Hudis CA; Münster PN
Semin Oncol; 1999 Feb; 26(1):35-47. PubMed ID: 10073560
[TBL] [Abstract][Full Text] [Related]
12. [High-dose chemotherapy for metastatic breast cancer].
Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
[TBL] [Abstract][Full Text] [Related]
13. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
Maraninchi D; Droz JP
Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
[TBL] [Abstract][Full Text] [Related]
14. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors.
Vaughan WP
Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558
[No Abstract] [Full Text] [Related]
15. Impact of neutropenia on delivering planned chemotherapy for solid tumours.
Khan S; Dhadda A; Fyfe D; Sundar S
Eur J Cancer Care (Engl); 2008 Jan; 17(1):19-25. PubMed ID: 18181887
[TBL] [Abstract][Full Text] [Related]
16. Dose-dense chemotherapy for primary breast cancer.
Kümmel S; Rezai M; Kimmig R; Schmid P
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
[TBL] [Abstract][Full Text] [Related]
17. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
18. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies].
Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F
An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338
[TBL] [Abstract][Full Text] [Related]
19. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
Burke MJ; Walterhouse DO; Jacobsohn DA; Duerst RE; Kletzel M
Pediatr Blood Cancer; 2007 Aug; 49(2):196-8. PubMed ID: 17417796
[TBL] [Abstract][Full Text] [Related]
20. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
